Navigation Links
DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes
Date:6/7/2008

l elevated postprandial spikes which are associated with dangerous cardiovascular complications. GlycoMark can detect 'hidden' glucose spikes, allowing physicians to target these spikes with specific treatments."

In a retrospective examination of studies (see below) evaluating the use of GlycoMark to monitor exenatide, pramlintide, sitagliptin, and biphasic insulin therapies, GlycoMark reflected changes in after-meal glucose levels more dynamically than A1C in moderately controlled patients - underscoring the ability of GlycoMark to detect underlying treatment effects on after-meal glucose not revealed by A1C. The study, "The Use of 1,5-Anhydroglucitol (GlycoMark) to Monitor New Classes of Therapies for Managing Post-meal Glucose in Patients with Diabetes," was presented at the recent American Association of Clinical Endocrinologists 2008 annual meeting in Orlando, Florida. Authors of the study included Steven Wittlin (University of Rochester), Toshikazu Yamanouchi (Teikyo University School of Medicine) and Antonio Ceriello (Warwick Medical School).

Exenatide Improves Postprandial Glucose (PPG) Control in Patients With Type 2 Diabetes as Measured by 1,5-Anhydroglucitol (GlycoMark)

Reference: Scientific Sessions of the American Diabetes Association - 2007 (David Kendall)

1,5-Anhydroglucitol (GlycoMark), a PPG Excursion Marker In Pramlintide-Treated Subjects

Reference: American Association of Clinical Endocrinologists 2007 Annual Meeting (Cameron Lush)

Efficacy and Safety of Sitagliptin Monotherapy in Japanese Patients with Type 2 Diabetes

Reference: Diabetes Research and Clinical Practice 2008 (Kenji Noaka)

Does serum 1,5-AG establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.

Reference: Diabetic Medicine 2008 (Alan Moses)

About GlycoMark

Glyc
'/>"/>

SOURCE GlycoMark, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
4. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
5. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, Ar...www.reportlinker.com/p0164303/Arthroscopes---A-Wor...procedures are on rise, owing to their mounting sc...kles, elbow, wrists, and hips, apart from knees. T...
(Date:12/2/2009)... , PALO ALTO, Calif., Dec. 2 /PRNewswire-F...ed that on November 25, 2009, Varian, Inc. filed w...s Annual Report on Form 10-K for the fiscal year e...ccessed through the Company,s web site at www.vari...ings," and then on "10-K" in the table shown. Sto...
(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, P...et Trends ,, http://www.reportlinker.com/p0...bal-Market-Trends.html ,, Global pharma indu...easing competition in generic markets, rising cost...
Breaking Medicine Technology:Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Association for Molecular Pathology comments to the SACGHS 49088 1Association for Molecular Pathology comments to the SACGHS 49088 2Income education important factors in heart disease risk 49084 1Income education important factors in heart disease risk 49084 2Safety Kleen Announces 24100 000 Commitment to American Heart Association Start 21 Dallas Heart Walk 49082 1Safety Kleen Announces 24100 000 Commitment to American Heart Association Start 21 Dallas Heart Walk 49082 2
...Bavituximab Equivalent and Irradiated Tumor,Cells ...trols in a,Preclinical Model of Brain Cancer--, LO...wswire-FirstCall/ -- Peregrine Pharmaceuticals, In...veloping targeted,monoclonal antibodies for the tr...ction, today announced preclinical studies,present...
...n to be therapeutically effective in a,mouse model... April 2007 - Santaris Pharma, the Danish,biopharm...,presented encouraging data at the American Associ...geles, showing that SPC2996, the,Company,s RNA Ant...reclinical model of human Chronic Lymphocytic Leuk...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6
(Date:12/2/2009)...UL, South Korea, Dec. 2 ...Korea Telecom (KT), MacroEye and Qualcomm Incorpor...TM) initiative, today announced the expansion of a...d applications through the "Seoul Family Helper" p... devices to caregivers and senior citizens in orde...
(Date:12/2/2009)..., BOSTON, Dec. 2 The Washington Po...s 8%. According to Coremetrics, a marketing optim...on Cyber Monday compared to Cyber Monday 2008. ,...nte Day Spas who reported today "Cyber Monday web...les rose 59%" - said Tiffany Amorosino, COO of Bel...
(Date:12/2/2009)...angioplasty within 90 minutes of hospital arrival,...thDay News) -- A nationwide program to get faster ...heart attack has dramatically reduced the time bet..., More than three-quarters of people with STEMI...cardiogram pattern that shows major blockage of a ...
(Date:12/2/2009)...used, the greater the sleep disturbances, study fi...s) -- The widely used club drug ecstasy appears to...chers. , "People who use ecstasy need to know t...diate and dangerous problems such as sleep apnea,"... School of Medicine in Baltimore, said in a news r...
(Date:12/2/2009)...olongs life remains unclear, researchers say , ... research suggests that enzyme replacement therapy...e with Fabry disease, a rare illness that affects ...e disease, linked to the lack of an enzyme that he...e fatal because it boosts the risk for a stroke, h...
Breaking Medicine News(10 mins):Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3Health News:Heart Attack Treatment Speeds Up Nationwide 2Health News:Heart Attack Treatment Speeds Up Nationwide 3Health News:Ecstasy Users at Higher Risk of Sleep Apnea 2
...eme Court,issued a 4-4 decision which will now all... are injured by a drug. Prior to this decision by ...ppeals had ruled in favor of,Michigan plaintiffs, ...he 2nd Circuit,s decision is now the law of the,co...
... States,Conference of Catholic Bishops (USCCB) wel...uary 27 approval of a new, bipartisan bill to comb...e is expected in March., Bishop Thomas G. Wenski ... Committee on Pro-Life Activities, both,affirmed k...
...Supports Diagnosis and Patient Access to ...arch 3 The Jeffrey Modell Foundation,(JMF) and Ta... to Lucile,Packard Children,s Hospital at Stanford...mpasses more than 150 diseases caused by an,immune...
...tool designed to measure a womans willingness to u... the sexual transmission of HIV), researchers at T... women who have used protective methods in the pas... has not been identified yet, several candidates a...
...fying Core Components of Spine Care Centers ...d CHICAGO, March 3 SpineMark Corporation,and NeuS...tion,s first,comprehensive survey of medical and s...Spine COE (Centers of Excellence) Survey(TM), the ...
...n German . ,, In humans, as in all mammals, sl...ave-sleep (SWS) alternates with dream phases, call...l studies suggest that information is processed an...ction of sleep by revealing overriding principles ...
Other Medicine News:Health News:Catholic Bishops Welcome New Bill for Global HIV/AIDS Relief 2Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 2Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 3Health News:Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Children's Hospital at Stanford 4Health News:Researchers develop new tool to predict who will use microbicides 2Health News:Researchers develop new tool to predict who will use microbicides 3Health News:SpineMark, NeuStrategy Partner to Conduct Nation's First Spine COE Survey(TM) 2Health News:SpineMark, NeuStrategy Partner to Conduct Nation's First Spine COE Survey(TM) 3Health News:'Power napping' in pigeons 2
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q43-R-CAB-ERB
...nomic chairs with concave seats and large backrest...eats, backrests, armrests, and casters and glides....n a variety of environments including: industry, e...health care and office. • With reinforced nyl...
...nomic chairs with concave seats and large backrest...eats, backrests, armrests, and casters and glides....n a variety of environments including: industry, e...health care and office. • With reinforced nyl...
BEC/1Q-ERB - Cast Aluminum Base - Model 1Q64-ERB
Medicine Products: